PURPOSE: The goal of this study is to summarize trends in rates of adverse events attributable to acetaminophen use, including hepatotoxicity and mortality. METHODS: A comprehensive analysis of data from three national surveillance systems estimated rates of acetaminophen-related events identified in different settings, including calls to poison centers (2008-2012), emergency department visits (2004-2012), and inpatient hospitalizations (1998-2011). Rates of acetaminophen-related events were calculated per setting, census population, and distributed drug units. RESULTS: Rates of poison center calls with acetaminophen-related exposures decreased from 49.5/1000 calls in 2009 to 43.5/1000 calls in 2012. Rates of emergency department visits for unintentional acetaminophen-related adverse events decreased from 58.0/1000 emergency department visits for adverse drug events in 2009 to 50.2/1000 emergency department visits in 2012. Rates of hospital inpatient discharges with acetaminophen-related poisoning decreased from 119.8/100 000 hospitalizations in 2009 to 108.6/100 000 hospitalizations in 2011. After 2009, population rates of acetaminophen-related events per 1 million census population decreased for poison center calls and hospitalizations, while emergency department visit rates remained stable. However, when accounting for drug sales, the rate of acetaminophen-related events (per 1 million distributed drug units) increased after 2009. Prior to 2009, the rates of acetaminophen-related hospitalizations had been slowly increasing (p-trend = 0.001). CONCLUSIONS: Acetaminophen-related adverse events continue to be a public health burden. Future studies with additional time points are necessary to confirm trends and determine whether recent risk mitigation efforts had a beneficial impact on acetaminophen-related adverse events. Published 2015. This article is a U.S. Government work and is in the public domain in the USA. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
PURPOSE: The goal of this study is to summarize trends in rates of adverse events attributable to acetaminophen use, including hepatotoxicity and mortality. METHODS: A comprehensive analysis of data from three national surveillance systems estimated rates of acetaminophen-related events identified in different settings, including calls to poison centers (2008-2012), emergency department visits (2004-2012), and inpatient hospitalizations (1998-2011). Rates of acetaminophen-related events were calculated per setting, census population, and distributed drug units. RESULTS: Rates of poison center calls with acetaminophen-related exposures decreased from 49.5/1000 calls in 2009 to 43.5/1000 calls in 2012. Rates of emergency department visits for unintentional acetaminophen-related adverse events decreased from 58.0/1000 emergency department visits for adverse drug events in 2009 to 50.2/1000 emergency department visits in 2012. Rates of hospital inpatient discharges with acetaminophen-related poisoning decreased from 119.8/100 000 hospitalizations in 2009 to 108.6/100 000 hospitalizations in 2011. After 2009, population rates of acetaminophen-related events per 1 million census population decreased for poison center calls and hospitalizations, while emergency department visit rates remained stable. However, when accounting for drug sales, the rate of acetaminophen-related events (per 1 million distributed drug units) increased after 2009. Prior to 2009, the rates of acetaminophen-related hospitalizations had been slowly increasing (p-trend = 0.001). CONCLUSIONS:Acetaminophen-related adverse events continue to be a public health burden. Future studies with additional time points are necessary to confirm trends and determine whether recent risk mitigation efforts had a beneficial impact on acetaminophen-related adverse events. Published 2015. This article is a U.S. Government work and is in the public domain in the USA. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest Journal: JAMA Date: 2006-10-18 Impact factor: 56.272
Authors: Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Barry H Rumack; Richard C Dart Journal: Clin Toxicol (Phila) Date: 2012-12 Impact factor: 4.467
Authors: Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Jody L Green; Barry H Rumack; Sandra L Giffin Journal: Clin Toxicol (Phila) Date: 2010-12 Impact factor: 4.467
Authors: Angelika D Manthripragada; Esther H Zhou; Daniel S Budnitz; Maribeth C Lovegrove; Mary E Willy Journal: Pharmacoepidemiol Drug Saf Date: 2011-02-03 Impact factor: 2.890
Authors: Anne M Larson; Julie Polson; Robert J Fontana; Timothy J Davern; Ezmina Lalani; Linda S Hynan; Joan S Reisch; Frank V Schiødt; George Ostapowicz; A Obaid Shakil; William M Lee Journal: Hepatology Date: 2005-12 Impact factor: 17.425
Authors: Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau Journal: JAMA Date: 2008-12-24 Impact factor: 56.272
Authors: Madhulika Eluri; Henry A Spiller; Marcel J Casavant; Thitphalak Chounthirath; Kristen A Conner; Gary A Smith Journal: Pain Med Date: 2018-12-01 Impact factor: 3.750
Authors: David W Kaufman; Judith P Kelly; Deena R Battista; Mary K Malone; Rachel B Weinstein; Saul Shiffman Journal: Br J Clin Pharmacol Date: 2019-03-18 Impact factor: 4.335
Authors: Tracy Pham; Jacqueline M Major; Grace Chai; David Moeny; Cunlin Wang; Michael D Blum Journal: Pharmacoepidemiol Drug Saf Date: 2017-03 Impact factor: 2.890
Authors: Saul Shiffman; Deena R Battista; Judith P Kelly; Mary K Malone; Rachel B Weinstein; David W Kaufman Journal: Br J Clin Pharmacol Date: 2018-03-25 Impact factor: 4.335
Authors: Sammy Saab; Peter G Konyn; Matthew R Viramontes; Melissa A Jimenez; Jonathan F Grotts; Wally Hamidzadah; Veronica P Dang; Negin L Esmailzadeh; Gina Choi; Francisco A Durazo; Mohamed M El-Kabany; Steven-Huy B Han; Myron J Tong Journal: J Clin Transl Hepatol Date: 2016-12-27